Further, the human p53 isoform Δ133p53β lacking the transactivation domain was observed to promote CSC features in breast cancer cell lines by expression of Sox2, Oct3/4, and Nanog in a Δ133p53β dependent manner (79). This evidence concerns the gene TP53 and breast cancer.